Taxonomic identification of pathogenic microorganisms and their toxic proteins

Abstract

The present invention describes a method for the binding of pathogenic microorganisms and their toxic proteins with ligands that have been covalently tethered at some distance from the surface of a substrate: distances of at least fifteen Å are required for microorganism binding ligand tethers and at least six Å are required for protein binding ligand tethers. The ligands described herein include heme compounds, siderophores, polysaccharides, and peptides specific for toxic proteins, outer membrane proteins and conjugated lipids. Non-binding components of the solution to be analyzed are separated from the bound fraction and binding is confirmed by detection of the analyte via microscopy, fluorescence, epifluorescence, luminescence, phosphorescence, radioactivity, or optical absorbance. By patterning numerous ligands in an array on a substrate surface it is possible to taxonomically identify the microorganism by analysis of the binding pattern of the sample to the array.

What is claimed:  
     
         21 . A method for taxonomic identification of a biological analyte comprising: 
 (a) exposing a solution containing the analyte to a ligand specific for the analyte of interest that has been covalently tethered to a substrate surface with a photostable linker at a distance of at least six Å for the capture of proteins;    (b) separating the bound analyte from the non-binding components of the solution containing the analyte by physical separation, washing or both; and    (c) interrogation of the ligand-tethered substrate surface for analyte binding.    
     
     
         22 . The method of  claim 21 , wherein the biological analyte is selected from the group comprised of: 
 (a) proteinaceous toxins; and    (b) cytosolic proteins.    
     
     
         23 . The method of  claim 21 , wherein the ligand is a peptide, usually three to twenty amino acids long, specific for a proteinaceous toxin.  
     
     
         24 . The method of  claim 21 , wherein the ligand is a peptide, usually three to twenty amino acids long, specific for a proteinaceous hormone.  
     
     
         25 . The method of  claim 21 , wherein the ligand is a peptide, usually three to twenty amino acids long, specific for a cytosolic protein.  
     
     
         26 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the intrinsic fluorescence of the protein.  
     
     
         27 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the fluorescence of a reactive dye conjugate exposed to the protein before capture of the analyte by the tethered ligand surface.  
     
     
         28 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the fluorescence of a reactive dye conjugate exposed to the protein after capture of the analyte by the tethered ligand surface.  
     
     
         29 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the radioactivity of a reactive compound exposed to the protein before capture of the analyte by the tethered ligand surface.  
     
     
         30 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the radioactivity of a reactive compound exposed to the protein after capture by the tethered ligand surface.  
     
     
         31 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the luminescence of a reactive dye conjugate exposed to the protein before capture of the analyte by the tethered ligand surface.  
     
     
         32 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the luminescence of a reactive dye conjugate exposed to the protein after capture of the analyte by the tethered ligand surface.  
     
     
         33 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the phosphorescence of a reactive dye conjugate exposed to the protein before capture of the analyte by the tethered ligand surface.  
     
     
         34 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the phosphorescence of a reactive dye conjugate exposed to the protein after capture of the analyte by the tethered ligand surface.  
     
     
         35 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the optical absorbance of a reactive dye conjugate exposed to the protein before capture of the analyte by the tethered ligand surface.  
     
     
         36 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the optical absorbance of a reactive dye conjugate exposed to the sample after capture of the analyte by the tethered ligand surface.  
     
     
         37 . The method of  claim 21 , wherein the detection of the captured analyte is accomplished through the fluorescent quenching of the fluorescent tethered ligand surface upon binding of the protein.  
     
     
         53 . The method of claim  51 , wherein the ligands utilized in the array are tethered with a photostable linker at a distance of at least six Å from the substrate surface for the capture of proteinaceous toxins.